This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

PMS-Repaglinide (2015-09-04)

Starting date:
September 4, 2015
Posting date:
September 16, 2015
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-54978

Affected Products

PMS-Repaglinide 0.5 mg

Reason

Voluntary recall initiated due to labelling error. A bottle of PMS-Repaglinide 0.5 mg was found to contain PMS-Repaglinide 1.0 mg tablet

Depth of distribution

Wholesalers and pharmacies across Canada

Affected products

PMS-Repaglinide 0.5 mg

DIN, NPN, DIN-HIM
DIN 02354926
Dosage form

Tablet

Strength

Repaglinide 0.5 mg

Lot or serial number

1402812

Companies
Recalling Firm
Pharmascience Inc.
100, 6111 Royalmount Avenue
Montreal
H4P 2T4
Quebec
CANADA
Marketing Authorization Holder
Pharmascience Inc.
100, 6111 Royalmount Avenue
Montreal
H4P 2T4
Quebec
CANADA

Date modified: